Near-infrared dye-conjugated hyaluronic acid derivative and contrast agent for optical imaging including them
US-2015374856-A1 · Dec 31, 2015 · US
US10022459B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10022459-B2 |
| Application number | US-201214126034-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 31, 2012 |
| Priority date | Jun 13, 2011 |
| Publication date | Jul 17, 2018 |
| Grant date | Jul 17, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A medical tissue-marker which enables the identification of a location even from the outside of an organ, can remain topical over a long period, and enables the easy identification of a marked location within the whole organ; also a manufacturing method for the medical tissue-marker. The medical tissue-marker includes a vesicle formed by the synthesis of a phospholipid and a near infrared fluorescent dye, and an emulsion formed by the synthesis of the phospholipid and an X-ray contrast medium, and has agglomerated clusters wherein the vesicle and the emulsion are contained in a hydrophilic solvent and a plurality of capsules are formed by use of an emulsifier.
Opening claim text (preview).
What is claimed is: 1. A medical tissue-marker comprising: a plurality of capsules formed and aggregated by an emulsifier, each capsule containing a hydrophilic solvent, a vesicle and an emulsion, wherein the vesicle is formed by combining a phospholipid and a near-infrared fluorescent dye, the emulsion is formed by combining the phospholipid and an X-ray contrast medium, the X-ray contrast medium is also provided outside of the capsules, the phospholipid is phosphatidylcholine and the X-ray contrast medium is a member selected from the group consisting of iodobenzene and derivatives thereof and barium salt and mixtures thereof. 2. The medical tissue-marker according to claim 1 , wherein the hydrophilic solvent includes water and an edible thickener.
liposome, i.e. bilayered vesicular structure · CPC title
General or multifunctional contrast agents, e.g. chelated agents · CPC title
Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery · CPC title
Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles · CPC title
Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.